Literature DB >> 32853771

Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.

David J López1, José A Rodríguez2, Sonia Bañuelos3.   

Abstract

Nucleophosmin (NPM1) is a mostly nucleolar protein with crucial functions in cell growth and homeostasis, including regulation of ribosome biogenesis and stress response. Such multiple activities rely on its ability to interact with nucleic acids and with hundreds of proteins, as well as on a dynamic subcellular distribution. NPM1 is thus regulated by a complex interplay between localization and interactions, further modulated by post-translational modifications. NPM1 is a homopentamer, with globular domains connected by long, intrinsically disordered linkers. This configuration allows NPM1 to engage in liquid-liquid phase separation phenomena, which could underlie a key role in nucleolar organization. Here, we will discuss NPM1 conformational and functional versatility, emphasizing its emerging, and still largely unexplored, role in DNA damage repair. Since NPM1 is altered in a subtype of acute myeloid leukaemia (AML), we will also present ongoing research on the molecular mechanisms underlying its pathogenic role and potential NPM1-targeting therapeutic strategies.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AML leukaemia; APE1; LLPS; NPM1; Nucleophosmin; nucleolus

Mesh:

Substances:

Year:  2020        PMID: 32853771     DOI: 10.1016/j.bbapap.2020.140532

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  13 in total

1.  NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.

Authors:  Claudia Morganti; Kyoko Ito; Chie Yanase; Amit Verma; Julie Teruya-Feldstein; Keisuke Ito
Journal:  EMBO Rep       Date:  2022-03-01       Impact factor: 9.071

2.  KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming.

Authors:  Xiao-Dan Ma; Shui-Dan Xu; Shi-Hui Hao; Kai Han; Jie-Wei Chen; Han Ling; Ri-Xin Chen; Xiao-Han Jin; Jing-Hua Cao; Jin-Long Lin; Qing-Jian Ou; Yu-Jing Fang; Zhi-Zhong Pan; Dan Xie; Feng-Wei Wang
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

Review 3.  Molecular Mechanisms Regulating the DNA Repair Protein APE1: A Focus on Its Flexible N-Terminal Tail Domain.

Authors:  David J López; José A Rodríguez; Sonia Bañuelos
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

4.  CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.

Authors:  Antonin Bouroumeau; Lucile Bussot; Sieme Hamaidia; Andrea Garcìa-Sandoval; Anna Bergan-Dahl; Patricia Betton-Fraisse; Samuel Duley; Cyril Fournier; Romain Aucagne; Annie Adrait; Yohann Couté; Anne McLeer; Edwige Col; Laurence David-Boudet; Tatiana Raskovalova; Marie-Christine Jacob; Claire Vettier; Simon Chevalier; Sylvain Carras; Christine Lefebvre; Caroline Algrin; Rémy Gressin; Mary B Callanan; Hervé Sartelet; Thierry Bonnefoix; Anouk Emadali
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

5.  Comprehensive Atlas of the Myelin Basic Protein Interaction Landscape.

Authors:  Evgeniya V Smirnova; Tatiana V Rakitina; Rustam H Ziganshin; Georgij P Arapidi; George A Saratov; Anna A Kudriaeva; Alexey A Belogurov
Journal:  Biomolecules       Date:  2021-11-03

6.  Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib.

Authors:  Petra Grbčić; Dora Fučkar Čupić; Tania Gamberi; Sandra Kraljević Pavelić; Mirela Sedić
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

Review 7.  Antagonising Chromatin Remodelling Activities in the Regulation of Mammalian Ribosomal Transcription.

Authors:  Kanwal Tariq; Ann-Kristin Östlund Farrants
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

8.  Functional characterization of NPM1-TYK2 fusion oncogene.

Authors:  Sudhakiranmayi Kuravi; Riley W Baker; Muhammad Umair Mushtaq; Irfan Saadi; Tara L Lin; Carolyn J Vivian; Anusha Valluripalli; Sunil Abhyankar; Siddhartha Ganguly; Wei Cui; Kojo S J Elenitoba-Johnson; Danny R Welch; Roy A Jensen; Yogen Saunthararajah; Joseph P McGuirk; Ramesh Balusu
Journal:  NPJ Precis Oncol       Date:  2022-01-18

9.  ERK signaling controls productive HIF-1 binding to chromatin and cancer cell adaptation to hypoxia through HIF-1α interaction with NPM1.

Authors:  Kreon Koukoulas; Antonis Giakountis; Angeliki Karagiota; Martina Samiotaki; George Panayotou; George Simos; Ilias Mylonis
Journal:  Mol Oncol       Date:  2021-09-09       Impact factor: 6.603

10.  NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.

Authors:  Xu-Sheng Liu; Lu-Meng Zhou; Ling-Ling Yuan; Yan Gao; Xue-Yan Kui; Xiao-Yu Liu; Zhi-Jun Pei
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.